School For Startups Radio

Greg Bullington – CEO & co-founder of Magnolia Medical Technologies From the time you have very legitimate proof and scientific evidence about the ability to dramatically improve standard of care in medicine to implementation at scale is 17 years. In health care, nobody wants to be first. Fortunately, no one wants to be last. Greg Bullington is CEO & co-founder of . Magnolia’s mission is to eliminate the misdiagnosis of sepsis. Sepsis is the #1 leading cause of death, costs and readmissions in hospitals nationwide. Diagnosis of sepsis is plagued by an average of 20% to over 50% of positive sepsis blood tests inaccurately providing false-positive results. Greg has raised over $125 million to date to finance the successful growth and development of the company. Magnolia’s flagship product, Steripath®, is the only FDA-cleared product family indicated to reduce blood culture contamination that causes false-positive diagnostic test results for bloodstream infections including sepsis, that can lead to har